TXINNO Bioscience
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $14M
Investors
- 7
About TXINNO Bioscience
Founded in 2020 and based in Yongin, South Korea, TXINNO Bioscience operates as a researcher and manufacturer of molecular immuno-oncology drugs. The company utilizes artificial intelligence technology to develop certain enzyme-inhibiting drugs and therapeutics that allow the activation of innate immunity in cancer patients.
Who invested in TXINNO Bioscience
7 investors across 3 rounds
See all investors in TXINNO Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TXINNO Bioscience
Who invested in TXINNO Bioscience?
TXINNO Bioscience has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TXINNO Bioscience raised?
TXINNO Bioscience has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TXINNO Bioscience last raise money?
TXINNO Bioscience's most recent round on record is a Series B, in Dec 2022.
What does TXINNO Bioscience do?
Founded in 2020 and based in Yongin, South Korea, TXINNO Bioscience operates as a researcher and manufacturer of molecular immuno-oncology drugs.
Where is TXINNO Bioscience headquartered?
TXINNO Bioscience is headquartered in Yongin, South Korea.
Which VCs invest in companies like TXINNO Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at TXINNO Bioscience's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like TXINNO Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.